208 related articles for article (PubMed ID: 38344996)
1. Small Molecule-Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment.
Wang T; Li M; Wei R; Wang X; Lin Z; Chen J; Wu X
Mol Pharm; 2024 Mar; 21(3):1038-1055. PubMed ID: 38344996
[TBL] [Abstract][Full Text] [Related]
2. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
Paulus J; Sewald N
J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs.
Zhang J; Hu F; Aras O; Chai Y; An F
ChemMedChem; 2024 Jun; 19(11):e202300720. PubMed ID: 38396351
[TBL] [Abstract][Full Text] [Related]
4. Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment.
Zhuang C; Guan X; Ma H; Cong H; Zhang W; Miao Z
Eur J Med Chem; 2019 Feb; 163():883-895. PubMed ID: 30580240
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand.
Amin TU; Emara R; Pal A; Aldawod H; Jiang G; Liang D; Haque Tuhin MT; Balgoname A; Patel AD; Alhamadsheh MM
J Med Chem; 2022 Nov; 65(22):15473-15486. PubMed ID: 36327103
[TBL] [Abstract][Full Text] [Related]
6. Antibody-Drug Conjugates-A Tutorial Review.
Baah S; Laws M; Rahman KM
Molecules; 2021 May; 26(10):. PubMed ID: 34063364
[TBL] [Abstract][Full Text] [Related]
7. Development of Antibody-Drug Conjugates: Future Perspective Towards Solid Tumor Treatment.
Pramanik D
Anticancer Agents Med Chem; 2023; 23(6):642-657. PubMed ID: 36321237
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy.
Parit S; Manchare A; Gholap AD; Mundhe P; Hatvate N; Rojekar S; Patravale V
Int J Pharm; 2024 Jun; 659():124211. PubMed ID: 38750981
[TBL] [Abstract][Full Text] [Related]
9. Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer.
Chen M; Cai L; Xiang Y; Zhong L; Shi J
Bioorg Chem; 2023 Dec; 141():106889. PubMed ID: 37813074
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates.
Lu N; Wu J; Tian M; Zhang S; Li Z; Shi L
Eur J Med Chem; 2024 Mar; 268():116233. PubMed ID: 38408390
[TBL] [Abstract][Full Text] [Related]
11. Antibody-Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions.
Yang T; Li W; Huang T; Zhou J
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569276
[TBL] [Abstract][Full Text] [Related]
12. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities.
Maiti R; Patel B; Patel N; Patel M; Patel A; Dhanesha N
Arch Pharm Res; 2023 May; 46(5):361-388. PubMed ID: 37071273
[TBL] [Abstract][Full Text] [Related]
13. Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement.
Jiang M; Li Q; Xu B
Drug Resist Updat; 2024 Jul; 75():101086. PubMed ID: 38677200
[TBL] [Abstract][Full Text] [Related]
14. Antibody Drug Conjugates for Cancer Therapy.
Polakis P
Pharmacol Rev; 2016 Jan; 68(1):3-19. PubMed ID: 26589413
[TBL] [Abstract][Full Text] [Related]
15. [Design of next generation antibody drug conjugates].
Zhu GD; Fu YX
Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles as modifiers of antibody-drug conjugate efficacy.
Barok M; Puhka M; Yazdi N; Joensuu H
J Extracell Vesicles; 2021 Feb; 10(4):e12070. PubMed ID: 33613875
[TBL] [Abstract][Full Text] [Related]
17. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
Hong Y; Nam SM; Moon A
Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
[TBL] [Abstract][Full Text] [Related]
18. Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
Ponziani S; Di Vittorio G; Pitari G; Cimini AM; Ardini M; Gentile R; Iacobelli S; Sala G; Capone E; Flavell DJ; Ippoliti R; Giansanti F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752132
[TBL] [Abstract][Full Text] [Related]
19. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
[TBL] [Abstract][Full Text] [Related]
20. A Patent Review on FDA-Approved Antibody-Drug Conjugates, Their Linkers and Drug Payloads.
Chia CSB
ChemMedChem; 2022 Jun; 17(11):e202200032. PubMed ID: 35384350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
